Paxlovid reduces long-COVID risk, VA study finds

Norge Nyheter Nyheter

Paxlovid reduces long-COVID risk, VA study finds
Norge Siste Nytt,Norge Overskrifter
  • 📰 axios
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

Pfizer's antiviral pill Paxlovid can reduce the risk of long COVID symptoms like organ damage, per a pre-print study released by the Dept. of Veterans Affairs.

can reduce the risk of long COVID symptoms like organ damage, according to a pre-print study the Department of Veterans Affairs released on Sunday.The study of 56,000 veterans who tested positive for the virus found those given the medication in the first five days of infection had a 25% decreased risk of developing 10 of 12 symptoms, such as heart, kidney or liver disease.

, which has been shown to reduce hospitalizations but also raised concerns about its contribution to COVID rebound.The study published on the pre-print server medRxiv has not yet been peer-reviewed and will need to be independently replicated.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

axios /  🏆 302. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Paxlovid reduces risk of long Covid, Veterans Affairs study finds | CNNPaxlovid reduces risk of long Covid, Veterans Affairs study finds | CNNPaxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also reduces the risk of long Covid, according to a new study by researchers at the US Department of Veterans Affairs.
Les mer »

Pfizer study says updated COVID boosters rev up protectionPfizer study says updated COVID boosters rev up protectionPfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies.
Les mer »

COVID Bivalent Booster Better vs Omicron Subvariants: PfizerCOVID Bivalent Booster Better vs Omicron Subvariants: PfizerOne month after receiving a booster with the bivalent vaccine, those older than 55 had 4x more neutralizing antibodies against these Omicron subvariants compared with people who received the original monovalent vaccine as a booster in a recent study.
Les mer »

CDC warns of tough winter as flu, RSV and covid collideCDC warns of tough winter as flu, RSV and covid collideThe United States continues to experience an unusually high and early uptick in flu and respiratory syncytial virus infections, straining a health-care system trying to recover from the worst of the coronavirus pandemic. While new coronavirus cases leveled off in recent weeks, federal health officials warned Friday they are confronting elevated levels of other viruses that are roaring back as pre-pandemic life returns and many Americans, particularly children, lack immunity. The Centers for Dise
Les mer »

LA County reports sudden rise in weekly COVID cases, warns of winter surgeLA County reports sudden rise in weekly COVID cases, warns of winter surgeAfter months of decline, LA County health officials have reported a sharp increase in the average daily number of new COVID-19 infections.
Les mer »



Render Time: 2025-03-12 23:31:09